Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
5.79
-0.20 (-3.34%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $318.04 million as of July 26, 2024. Its market cap has increased by 43.85% in one year.
Market Cap
318.04M
Enterprise Value
138.23M
1-Year Change
43.85%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $318.04M, a decrease of -60.57%. That is a compound annual growth rate of -21.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 329.00M | 40.54% |
| Dec 29, 2023 | 234.10M | -19.02% |
| Dec 30, 2022 | 289.10M | -50.82% |
| Dec 31, 2021 | 587.80M | -81.20% |
| Dec 31, 2020 | 3.13B | 287.66% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 350.74M |
| Inozyme Pharma | 350.72M |
| Black Diamond Therapeutics | 349.33M |
| ALX Oncology Holdings | 346.47M |
| Cabaletta Bio | 342.28M |
| Kamada | 337.95M |
| DocGo | 337.20M |
| ModivCare | 336.66M |